{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:06:08Z","timestamp":1793642768689,"version":"4.5.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002642","name":"Korea University","doi-asserted-by":"publisher","award":["K2327351"],"award-info":[{"award-number":["K2327351"]}],"id":[{"id":"10.13039\/501100002642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000171","name":"Division of Human Resource Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010418","name":"Institute for Information and Communications Technology Promotion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["2022M3E5F3081268"],"award-info":[{"award-number":["2022M3E5F3081268"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2024-00441029"],"award-info":[{"award-number":["RS-2024-00441029"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Structural Biology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.sbi.2025.102995","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T07:54:45Z","timestamp":1739865285000},"page":"102995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["From part to whole: AI-driven progress in fragment-based drug discovery"],"prefix":"10.1016","volume":"91","author":[{"given":"Jinhyeok","family":"Yoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonkyeong","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3462-0243","authenticated-orcid":false,"given":"Woong-Hee","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sbi.2025.102995_bib1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nchem.217","article-title":"The rise of fragment-based drug discovery","volume":"1","author":"Murray","year":"2009","journal-title":"Nat Chem"},{"key":"10.1016\/j.sbi.2025.102995_bib2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fmolb.2020.00180","article-title":"Application of fragment-based drug discovery to versatile targets","volume":"7","author":"Li","year":"2020","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.sbi.2025.102995_bib3","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.3390\/molecules24234309","article-title":"Concepts and core principles of fragment-based drug design","volume":"24","author":"Kirsch","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.sbi.2025.102995_bib4","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.drudis.2020.03.016","article-title":"Covalent fragment libraries in drug discovery","volume":"25","author":"Keeley","year":"2020","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.sbi.2025.102995_bib5","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrd.2016.109","article-title":"Twenty years on: the impact of fragments on drug discovery","volume":"15","author":"Erlanson","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.sbi.2025.102995_bib6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.tibs.2023.01.008","article-title":"Fragment-based drug discovery supports drugging \u2018undruggable\u2019 protein-protein interactions","volume":"48","author":"Wang","year":"2023","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.sbi.2025.102995_bib7","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1002\/1878-0261.13277","article-title":"Fragment-based drug discovery-the importance of high-quality molecule libraries","volume":"16","author":"Bon","year":"2022","journal-title":"Mol Oncol"},{"key":"10.1016\/j.sbi.2025.102995_bib8","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.1021\/acs.jmedchem.7b00947","article-title":"Discovery of fragment-derived small molecules for\u00a0in\u00a0vivo inhibition of ketohexokinase (KHK)","volume":"60","author":"Huard","year":"2017","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.sbi.2025.102995_bib9","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S1359-6446(03)02831-9","article-title":"A\u00a0\u201crule of three\u201d for fragment-based lead discovery?","volume":"8","author":"Congreve","year":"2003","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.sbi.2025.102995_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.sbi.2025.102995_bib11","series-title":"Fragment-based drug discovery: lessons and outlook","first-page":"31","author":"Erlanson","year":"2015"},{"key":"10.1016\/j.sbi.2025.102995_bib12","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1016\/j.sbi.2025.102995_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nchem.1243","article-title":"Quantifying the chemical beauty of drugs","volume":"4","author":"Bickerton","year":"2012","journal-title":"Nat Chem"},{"key":"10.1016\/j.sbi.2025.102995_bib14","first-page":"1","article-title":"Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions","volume":"1","author":"Ertl","year":"2009","journal-title":"J\u00a0Cheminf"},{"key":"10.1016\/j.sbi.2025.102995_bib15","doi-asserted-by":"crossref","first-page":"17833","DOI":"10.1021\/acs.jmedchem.4c01857","article-title":"Deep-learning-driven discovery of SN3-1, a potent NLRP3 inhibitor with therapeutic potential for inflammatory diseases","volume":"67","author":"Shi","year":"2024","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.sbi.2025.102995_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/pro.5007","article-title":"An ensemble machine learning model generates a focused screening library for the identification of CDK8 inhibitors","volume":"33","author":"Lin","year":"2024","journal-title":"Protein Sci"},{"key":"10.1016\/j.sbi.2025.102995_bib17","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.1021\/acs.jmedchem.4c00091","article-title":"Artificial intelligence-assisted optimization of antipigmentation tyrosinase inhibitors: De Novo molecular generation based on a low activity lead compound","volume":"67","author":"Cai","year":"2024","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.sbi.2025.102995_bib18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/ddc3010009","article-title":"Revolutionizing drug discovery: a comprehensive review of AI applications","volume":"3","author":"Dhudum","year":"2024","journal-title":"Drugs Drug Candidates"},{"key":"10.1016\/j.sbi.2025.102995_bib19","article-title":"M.\u00a0Welling Auto-encoding variational bayes","author":"Kingma","year":"2013","journal-title":"arXiv preprint"},{"key":"10.1016\/j.sbi.2025.102995_sref20","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1021\/acs.jcim.1c01311","article-title":"Incorporating target-specific pharmacophoric information into deep generative models for fragment elaboration","volume":"62","author":"Hadfield","year":"2022","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1016\/j.sbi.2025.102995_bib21","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1021\/acs.jmedchem.5b01980","article-title":"Identifying interactions that determine fragment binding at protein hotspots","volume":"59","author":"Radoux","year":"2016","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.sbi.2025.102995_bib22","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","article-title":"Zinc 15 \u2013 ligand discovery for everyone","volume":"55","author":"Sterling","year":"2015","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1016\/j.sbi.2025.102995_bib23","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1021\/acs.jcim.8b00545","article-title":"Comparative assessment of scoring functions: the CASF-2016 update","volume":"59","author":"Su","year":"2019","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1016\/j.sbi.2025.102995_sref24","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202200215","article-title":"Fragment-based deep molecular generation using hierarchical chemical graph representation and multi-resolution graph variational autoencoder","volume":"42","author":"Gao","year":"2023","journal-title":"Mol Inform"},{"key":"10.1016\/j.sbi.2025.102995_bib25","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.sbi.2025.102995_bib26","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1093\/bioinformatics\/btu173","article-title":"molBLOCKS: decomposing small molecule sets and uncovering enriched fragments","volume":"30","author":"Ghersi","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.sbi.2025.102995_bib27","article-title":"Neural\u00a0message passing for quantum chemistry","author":"Gilmer","year":"2017","journal-title":"arXiv preprint"},{"key":"10.1016\/j.sbi.2025.102995_sref28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s42004-022-00733-0","article-title":"Generative and reinforcement learning approaches for the automated de novo design of bioactive compounds","volume":"5","author":"Korshunova","year":"2022","journal-title":"Commun Chem"},{"key":"10.1016\/j.sbi.2025.102995_sref29","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.106721","article-title":"ReBADD-SE: multi-objective molecular optimisation using SELFIES fragment and off-policy self-critical sequence training","volume":"157","author":"Choi","year":"2023","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.sbi.2025.102995_bib30","article-title":"Self-referencing embedded strings (SELFIES): a 100% robust molecular string representation","volume":"1","author":"Krenn","year":"2020","journal-title":"Mach Lear : Sci Technol"},{"key":"10.1016\/j.sbi.2025.102995_bib31","article-title":"Inferring algorithmic patterns with stack-augmented recurrent nets","author":"Joulin","year":"2015","journal-title":"arXiv preprint"},{"key":"10.1016\/j.sbi.2025.102995_bib32","article-title":"Rule of five violations among the FDA-approved small molecule protein kinase inhibitors","volume":"191","author":"Roskoski","year":"2023","journal-title":"Pharamcol Res"},{"key":"10.1016\/j.sbi.2025.102995_bib33","article-title":"Tensor field networks: rotation-and translation-equivariant neural networks for 3D point clouds","author":"Thomas","year":"2018","journal-title":"arXiv preprint"},{"key":"10.1016\/j.sbi.2025.102995_bib34","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1021\/acscentsci.3c00572","article-title":"Geometric deep learning for structure-based ligand design","volume":"9","author":"Powers","year":"2023","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.sbi.2025.102995_bib35","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1021\/jm048957q","article-title":"The PDBbind database: methodologies and updates","volume":"48","author":"Wang","year":"2005","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.sbi.2025.102995_bib36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/bioinformatics\/btu626","article-title":"PDB-wide collection of binding data: current status of the PDBbind database","volume":"31","author":"Liu","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.sbi.2025.102995_bib37","article-title":"P.\u00a0Denoising diffusion probabilistic models","author":"Ho","year":"2020","journal-title":"arXiv preprint"},{"key":"10.1016\/j.sbi.2025.102995_bib38","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s44222-023-00114-9","article-title":"Diffusion models in bioinformatics and computational biology","volume":"2","author":"Guo","year":"2024","journal-title":"Nat Rev Bioeng"},{"key":"10.1016\/j.sbi.2025.102995_bib39","article-title":"Autoregressive fragment-based diffusion for pocket-aware ligand design","author":"Ghorbani","year":"2023","journal-title":"arXiv preprint"},{"key":"10.1016\/j.sbi.2025.102995_bib40","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1021\/acs.jcim.0c00411","article-title":"Three-dimensional convolutional neural networks and a cross-docked data set for structure-based drug design","volume":"60","author":"Francoeur","year":"2020","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1016\/j.sbi.2025.102995_bib41","first-page":"1137","article-title":"A\u00a0neural probabilistic language model","volume":"3","author":"Bengio","year":"2003","journal-title":"J\u00a0Mach Learn Res"},{"key":"10.1016\/j.sbi.2025.102995_sref42","article-title":"Fragment and geometry aware tokenization of molecules for structure-based drug design using language models","author":"Fu","year":"2024","journal-title":"arXiv preprint"},{"key":"10.1016\/j.sbi.2025.102995_bib43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1109\/MCI.2022.3155308","article-title":"Deep evolutionary learning for molecular design","volume":"17","author":"Grantham","year":"2022","journal-title":"IEEE Comput Intell Mag"},{"key":"10.1016\/j.sbi.2025.102995_sref44","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.920747","article-title":"Multi-objective drug design based on graph-fragment molecular representation and deep evolutionary learning","volume":"13","author":"Mukaidaisi","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.sbi.2025.102995_bib45","article-title":"Junction tree variational autoencoder for molecular graph generation","author":"Jin","year":"2018","journal-title":"arXiv preprint"},{"key":"10.1016\/j.sbi.2025.102995_bib46","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1021\/acs.jcim.0c00675","article-title":"ZINC20-A free ultralarge-scale chemical database for ligand discovery","volume":"60","author":"Irwin","year":"2020","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1016\/j.sbi.2025.102995_bib47","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"D1","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.sbi.2025.102995_bib48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrd2220","article-title":"A\u00a0decade of fragment-based drug design: strategic advances and lessons learned","volume":"6","author":"Hajduk","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.sbi.2025.102995_bib49","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1039\/D1CB00011J","article-title":"Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradation","volume":"2","author":"Bond","year":"2021","journal-title":"RSC Chem Biol"},{"key":"10.1016\/j.sbi.2025.102995_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105921","article-title":"Applications of \"linkers\" in fragment-based drug design","volume":"127","author":"Wu","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.sbi.2025.102995_bib51","doi-asserted-by":"crossref","first-page":"11420","DOI":"10.1021\/acs.jmedchem.0c00242","article-title":"Fragment linking strategies for structure-based drug design","volume":"63","author":"Bancet","year":"2020","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.sbi.2025.102995_bib52","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/cbdd.14120","article-title":"Development of potent inhibitors by fragment-linking strategies","volume":"100","author":"Bedwell","year":"2022","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.sbi.2025.102995_bib53","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1021\/acs.jcim.9b01120","article-title":"Deep generative models for 3D linker design","volume":"60","author":"Imrie","year":"2020","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1016\/j.sbi.2025.102995_bib54","article-title":"3DLinker: an E (3) equivariant variational autoencoder for molecular linker design","author":"Huang","year":"2022","journal-title":"arXiv preprint"},{"key":"10.1016\/j.sbi.2025.102995_bib55","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1021\/acs.jcim.2c00982","article-title":"DRlinker: deep reinforcement learning for optimization in fragment linking design","volume":"62","author":"Tan","year":"2022","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1016\/j.sbi.2025.102995_bib56","article-title":"Reinforcement learning-driven linker design via fast attention-based point cloud alignment","author":"Neeser","year":"2023","journal-title":"arXiv preprint"},{"key":"10.1016\/j.sbi.2025.102995_bib57","article-title":"A\u00a0point set generation network for 3D object reconstruction from a single image","author":"Fan","year":"2016","journal-title":"arXiv preprint"},{"key":"10.1016\/j.sbi.2025.102995_bib58","article-title":"A.\u00a0Independent SE(3)-equivariant models for end-to-end rigid protein docking","author":"Ganea","year":"2021","journal-title":"arXiv preprint"},{"key":"10.1016\/j.sbi.2025.102995_bib59","article-title":"EquiBind: geometric deep learning for drug binding structure prediction","author":"St\u00e4rk","year":"2022","journal-title":"arXiv preprint"},{"key":"10.1016\/j.sbi.2025.102995_bib60","doi-asserted-by":"crossref","first-page":"D1367","DOI":"10.1093\/nar\/gkac946","article-title":"PROTAC-DB 2.0: an updated database of PROTACs","volume":"51","author":"Weng","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.sbi.2025.102995_sref61","first-page":"392","article-title":"Link-INVENT: generative linker design with reinforcement learning","volume":"2","author":"Guo","year":"2023","journal-title":"Dig Dis"},{"key":"10.1016\/j.sbi.2025.102995_bib62","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1021\/acs.jcim.2c01287","article-title":"Fragment linker prediction using the deep encoder-decoder network for PROTACs drug design","volume":"63","author":"Kao","year":"2023","journal-title":"J\u00a0Chem Inf Model"}],"container-title":["Current Opinion in Structural Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959440X25000132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959440X25000132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T09:23:43Z","timestamp":1774517023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959440X25000132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":62,"alternative-id":["S0959440X25000132"],"URL":"https:\/\/doi.org\/10.1016\/j.sbi.2025.102995","relation":{},"ISSN":["0959-440X"],"issn-type":[{"value":"0959-440X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From part to whole: AI-driven progress in fragment-based drug discovery","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Structural Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sbi.2025.102995","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102995"}}